Immunosuppressive Drugs in Organ Transplant Recipients – Rationale for Critical Selection

2012 ◽  
pp. 36-48 ◽  
Author(s):  
Fabien Stucker ◽  
Hans-Peter Marti ◽  
Robert E. Hunger
Keyword(s):  
Organ Transplant ◽  
Immunosuppressive Drugs ◽  
Transplant Recipients ◽  
Organ Transplant Recipients

Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients

2015 ◽  
Vol 11 (6) ◽  
pp. 921-936 ◽  
Author(s):  
Louise M Andrews ◽  
Natalia Riva ◽  
Brenda C de Winter ◽  
Dennis A Hesselink ◽  
Saskia N de Wildt ◽  
...  
Keyword(s):  
Organ Transplant ◽  
Immunosuppressive Drugs ◽  
Solid Organ Transplant ◽  
Solid Organ ◽  
Transplant Recipients ◽  
Organ Transplant Recipients ◽  
Solid Organ Transplant Recipients

scholarly journals Lung cancer in solid organ transplant recipients

2021 ◽  
Vol 23 (4) ◽  
pp. 19-25
Author(s):  
A. V. Nikulin ◽  
I. V. Pashkov ◽  
Ya. S. Yakunin
Keyword(s):  
Lung Cancer ◽  
Malignant Tumors ◽  
Organ Transplant ◽  
Immunosuppressive Drugs ◽  
Solid Organ Transplant ◽  
Screening Methods ◽  
Solid Organ ◽  
Transplant Recipients ◽  
Organ Transplant Recipients ◽  
Solid Organ Transplant Recipients

Lung cancer remains the leading cause of cancer mortality worldwide. Solid organ transplant recipients are at risk of developing malignant tumors, including lung cancer, due to long-term use of immunosuppressive drugs. Development of cancer, including lung cancer, in this patient cohort, has a number of peculiarities. Moreover, malignant tumors in these patients are difficult to treat and have a poorer prognosis. This review presents a study of the issues concerning the mechanisms of lung cancer development, screening methods and treatment in solid organ transplant recipients.

Sign in / Sign up

Export Citation Format

Share Document